Press Releases

Emmaus Life Sciences Reports Annual Financial Results for 2020 and Provides Updated Business Review

May 04, 2021 9:30am EDT

Emmaus Life Sciences Provides Form 10-K Filing Update

Apr 15, 2021 2:16pm EDT

Emmaus Life Sciences Announces Collaboration with Kainos Medicine for Preclinical Development of IRAK4 Inhibitor as Potential Anti-Cancer Drug

Mar 02, 2021 11:44am EST

Emmaus Life Sciences Reports Increase in Sales Volume in 2020

Jan 27, 2021 11:30am EST

Emmaus Life Sciences Reports Annual Financial Results for 2019 and Provides Business Review

Jan 25, 2021 12:13pm EST

Michigan Revises Prior Authorization Criteria for Endari®

Dec 10, 2020 11:30am EST

Emmaus Life Sciences Launches Endari® Support Program

Dec 08, 2020 11:30am EST

Endari® Granted Orphan Drug Status in Switzerland

Dec 03, 2020 11:20am EST

Emmaus Life Sciences Submits Temporary License Application in Bahrain for Endari®

Nov 10, 2020 11:25am EST

FDA Approves Updated Label for Endari®

Nov 03, 2020 11:30am EST